INTERACTION OF DEOXYURIDINE WITH FLUOROURACIL AND DIPYRIDAMOLE IN A HUMAN-COLON CANCER CELL-LINE

被引：27
作者：
GREM, JL
MULCAHY, RT
MILLER, EM
ALLEGRA, CJ
FISCHER, PH
机构：
[1] NCI,DIV CANC TREATMENT,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205
[2] UNIV WISCONSIN,CTR CLIN CANC,DEPT HUMAN ONCOL,MADISON,WI 53792
来源：
BIOCHEMICAL PHARMACOLOGY | 1989年 / 38卷 / 01期
关键词：
D O I：
10.1016/0006-2952(89)90148-2
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 59
页数：9
相关论文
共 55 条
[1]  
ALLEGRA CJ, 1985, J BIOL CHEM, V260, P9720
[2]   TUMOR 5-FLUORODEOXYURIDYLATE CONCENTRATION AS A DETERMINANT OF 5-FLUOROURACIL RESPONSE [J].
ARDALAN, B ;
BUSCAGLIA, MD ;
SCHEIN, PS .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (16) :2009-2013
[3]   AN UPDATE ON THE BIOCHEMISTRY OF 5-FLUOROURACIL [J].
ARDALAN, B ;
GLAZER, R .
CANCER TREATMENT REVIEWS, 1981, 8 (03) :157-167
[4]  
ARDALAN B, 1980, CANCER RES, V40, P1431
[5]  
BENZ C, 1981, CANCER RES, V41, P994
[6]  
BERGER SH, 1984, MOL PHARMACOL, V25, P303
[7]  
BRATTAIN MG, 1981, CANCER RES, V41, P1751
[8]  
BREITMAN TR, 1963, BIOCHIM BIOPHYS ACTA, V67, P153
[9]  
BRESNICK E, 1965, J BIOL CHEM, V240, P3967
[10]   EFFECT OF DENOVO PURINE SYNTHESIS INHIBITORS ON 5-FLUOROURACIL METABOLISM AND CYTO-TOXICITY [J].
CADMAN, E ;
BENZ, C ;
HEIMER, R ;
OSHAUGHNESSY, J .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (17) :2469-2472
123456